Arrowhead Pharmaceuticals Inc (ARWR)

Add to Watchlists
Create an Alert
Quickflows
65.95 -0.78  -1.17% NASDAQ Jul 27, 20:00 USD
View Full Chart
Price Chart
View All Key Stats

Key Stats

View All ARWR News

News

View All Events

Events

Date Type Description
08/05/2021 Earnings Results Q3 2021 Earnings Results
08/05/2021 16:30 EST Earnings Calls Q3 2021 Earnings Call
05/04/2021 Earnings Results Q2 2021 Earnings Results
05/04/2021 16:30 EST Earnings Calls Q2 2021 Earnings Call
03/18/2021 13:00 EST AGM 2020 Annual General Meeting
02/04/2021 Earnings Results Q1 2021 Earnings Results
02/04/2021 16:30 EST Earnings Calls Q1 2021 Earnings Call
11/23/2020 Earnings Results Q4 2020 Earnings Results
11/23/2020 16:30 EST Earnings Calls Q4 2020 Earnings Call
08/05/2020 16:30 EST Earnings Calls Q3 2020 Earnings Call
View All Performance Charts

Total Returns Comparison

Fundamentals

Income Statement View Statement

Revenue (TTM) 89.12M
Total Expenses (TTM) 207.47M
Net Income (TTM) -109.59M

Balance Sheet View Statement

Total Assets (Quarterly) 756.80M
Total Liabilities (Quarterly) 311.25M
Shareholders Equity (Quarterly) 445.55M

Cash Flow Statement View Statement

Cash from Operations (TTM) 180.67M
Cash from Investing (TTM) -75.82M
Cash from Financing (TTM) 10.87M

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.
  • URL: https://www.arrowheadpharma.com
  • Investor Relations URL: https://ir.arrowheadpharma.com/
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Mid Cap/Growth
  • Next Earnings Release: Aug. 05, 2021
  • Last Earnings Release: May. 04, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Analyst Coverage

Consensus Recommendations
Buy Recommendations Upgrade
Outperform Recommendations Upgrade
Hold Recommendations Upgrade
Underperform Recommendations Upgrade
Sell Recommendations Upgrade
Consensus Recommendation Upgrade
Consensus Rating Upgrade
Target Price
Price 65.95
Price Target Upgrade
Price Target Upside (Daily) Upgrade

Top Fund Holders

Symbol Name Weighting
GNOM Global X Genomics & Biotechnology ETF 3.69%
PBE Invesco Dynamic Biotech & Genome ETF 2.48%
BIOUX Baron Opportunity R6 2.48%
GOFFX Invesco Global Opportunities R5 2.11%
FBIOX Fidelity® Select Biotechnology 0.99%
VTWG Vanguard Russell 2000 Growth ETF 0.54%
IWO iShares Russell 2000 Growth ETF 0.47%
FSSNX Fidelity® Small Cap Index 0.29%
VRTIX Vanguard Russell 2000 Index I 0.28%
VTWO Vanguard Russell 2000 ETF 0.28%
SWSSX Schwab Small Cap Index 0.27%
IWM iShares Russell 2000 ETF 0.24%

Comparables

Edit
CTXR Citius Pharmaceuticals Inc
ALEC Alector Inc
MEDS Trxade Health Inc
JNJ Johnson & Johnson
ALNY Alnylam Pharmaceuticals Inc

Other Resources

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.